AtriCure, Inc. (ATRC)

AtriCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	399.25	330.38	274.33	206.53	230.81
Revenue Growth (YoY)	20.84%	20.43%	32.83%	-10.52%	14.47%
Cost of Revenue	98.88	84.44	68.47	57.22	60.47
Gross Profit	300.37	245.94	205.86	149.31	170.34
Selling, General & Admin	253.14	231.27	204.65	150.83	167.14
Research & Development	73.92	57.34	48.51	43.07	41.23
Other Operating Expenses	0	0	82.3	0	0
Operating Expenses	327.05	288.61	335.46	193.9	208.37
Operating Income	-26.68	-42.67	-129.6	-44.59	-38.04
Interest Expense / Income	6.93	4.99	4.92	4.89	4.11
Other Expense / Income	-3.76	-1.46	-184.9	-1.43	-7.15
Pretax Income	-29.85	-46.2	50.39	-48.04	-35
Income Tax	0.59	0.27	0.19	0.11	0.2
Net Income	-30.44	-46.47	50.2	-48.16	-35.19
Shares Outstanding (Basic)	46	46	45	42	38
Shares Outstanding (Diluted)	46	46	46	42	38
Shares Change	1.24%	-0.65%	9.29%	12.07%	10.27%
EPS (Basic)	-0.66	-1.02	1.11	-1.14	-0.94
EPS (Diluted)	-0.66	-1.02	1.09	-1.14	-0.94
Free Cash Flow	-37.51	-39.02	-23.53	-25.13	-27.95
Free Cash Flow Per Share	-0.81	-0.85	-0.52	-0.60	-0.74
Gross Margin	75.23%	74.44%	75.04%	72.29%	73.80%
Operating Margin	-6.68%	-12.92%	-47.24%	-21.59%	-16.48%
Profit Margin	-7.62%	-14.06%	18.30%	-23.32%	-15.25%
Free Cash Flow Margin	-9.40%	-11.81%	-8.58%	-12.17%	-12.11%
Effective Tax Rate	-	-	0.37%	-	-
EBITDA	-8.11	-29.5	65.75	-33.61	-21.52
EBITDA Margin	-2.03%	-8.93%	23.97%	-16.27%	-9.32%
Depreciation & Amortization	14.81	11.71	10.44	9.55	9.37
EBIT	-22.92	-41.21	55.31	-43.16	-30.88
EBIT Margin	-5.74%	-12.47%	20.16%	-20.90%	-13.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).